<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.3" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments on: Darapladib in conjunction with statin drugs may reduce risk of heart attacks and stroke</title>
	<link>http://www.cardiologyproductguide.com/blog/2008/05/15/darapladib-in-conjunction-with-statin-drugs-may-reduce-risk-of-heart-attacks-and-stroke/</link>
	<description>A comprehensive guide to cardiology products for medical professionals</description>
	<pubDate>Tue, 06 Jan 2009 11:56:12 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.3</generator>
		<item>
		<title>By: Paul</title>
		<link>http://www.cardiologyproductguide.com/blog/2008/05/15/darapladib-in-conjunction-with-statin-drugs-may-reduce-risk-of-heart-attacks-and-stroke/#comment-8</link>
		<dc:creator>Paul</dc:creator>
		<pubDate>Fri, 16 May 2008 23:17:49 +0000</pubDate>
		<guid>http://www.cardiologyproductguide.com/blog/2008/05/15/darapladib-in-conjunction-with-statin-drugs-may-reduce-risk-of-heart-attacks-and-stroke/#comment-8</guid>
		<description>Sounds good, but without outcomes data, this means nothing. So what if it lowers a marker that has been shown to be correlated with high risk (but not independent of LDL).  Until someone can show that lowering Lp-PLA2 has a positive effect, it has not utility.</description>
		<content:encoded><![CDATA[<p>Sounds good, but without outcomes data, this means nothing. So what if it lowers a marker that has been shown to be correlated with high risk (but not independent of LDL).  Until someone can show that lowering Lp-PLA2 has a positive effect, it has not utility.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
